nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Vertigo—Altretamine—ovarian cancer	0.0247	0.0251	CcSEcCtD
Methocarbamol—Leukopenia—Altretamine—ovarian cancer	0.0246	0.025	CcSEcCtD
Methocarbamol—Convulsion—Altretamine—ovarian cancer	0.0238	0.0242	CcSEcCtD
Methocarbamol—Dizziness—Altretamine—ovarian cancer	0.0148	0.0151	CcSEcCtD
Methocarbamol—Thrombophlebitis—Vinorelbine—ovarian cancer	0.0143	0.0145	CcSEcCtD
Methocarbamol—Vomiting—Altretamine—ovarian cancer	0.0143	0.0145	CcSEcCtD
Methocarbamol—Nausea—Altretamine—ovarian cancer	0.0133	0.0135	CcSEcCtD
Methocarbamol—Pain—Carboplatin—ovarian cancer	0.0133	0.0135	CcSEcCtD
Methocarbamol—Body temperature increased—Carboplatin—ovarian cancer	0.0123	0.0125	CcSEcCtD
Methocarbamol—Jaundice—Chlorambucil—ovarian cancer	0.0122	0.0124	CcSEcCtD
Methocarbamol—Carvedilol—VEGFA—ovarian cancer	0.0108	0.689	CrCbGaD
Methocarbamol—Jaundice—Melphalan—ovarian cancer	0.0106	0.0108	CcSEcCtD
Methocarbamol—Lightheadedness—Paclitaxel—ovarian cancer	0.0102	0.0104	CcSEcCtD
Methocarbamol—Thrombophlebitis—Paclitaxel—ovarian cancer	0.0096	0.00975	CcSEcCtD
Methocarbamol—Nystagmus—Epirubicin—ovarian cancer	0.00916	0.00931	CcSEcCtD
Methocarbamol—Nasal congestion—Paclitaxel—ovarian cancer	0.00912	0.00927	CcSEcCtD
Methocarbamol—Flushing—Melphalan—ovarian cancer	0.00908	0.00922	CcSEcCtD
Methocarbamol—Injury—Paclitaxel—ovarian cancer	0.00904	0.00919	CcSEcCtD
Methocarbamol—Angioedema—Chlorambucil—ovarian cancer	0.00893	0.00907	CcSEcCtD
Methocarbamol—Leukopenia—Chlorambucil—ovarian cancer	0.00875	0.00889	CcSEcCtD
Methocarbamol—Lightheadedness—Docetaxel—ovarian cancer	0.00868	0.00882	CcSEcCtD
Methocarbamol—Nystagmus—Doxorubicin—ovarian cancer	0.00848	0.00861	CcSEcCtD
Methocarbamol—Convulsion—Chlorambucil—ovarian cancer	0.00847	0.0086	CcSEcCtD
Methocarbamol—Thrombophlebitis—Docetaxel—ovarian cancer	0.00814	0.00827	CcSEcCtD
Methocarbamol—Confusional state—Chlorambucil—ovarian cancer	0.00804	0.00817	CcSEcCtD
Methocarbamol—Angioedema—Topotecan—ovarian cancer	0.00795	0.00807	CcSEcCtD
Methocarbamol—Flushing—Vinorelbine—ovarian cancer	0.00793	0.00806	CcSEcCtD
Methocarbamol—Leukopenia—Topotecan—ovarian cancer	0.00779	0.00791	CcSEcCtD
Methocarbamol—Leukopenia—Melphalan—ovarian cancer	0.00762	0.00775	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00745	0.00757	CcSEcCtD
Methocarbamol—Convulsion—Melphalan—ovarian cancer	0.00738	0.0075	CcSEcCtD
Methocarbamol—Anaphylactic shock—Topotecan—ovarian cancer	0.0071	0.00721	CcSEcCtD
Methocarbamol—Dyspepsia—Chlorambucil—ovarian cancer	0.00702	0.00713	CcSEcCtD
Methocarbamol—Anaphylactic shock—Melphalan—ovarian cancer	0.00695	0.00706	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00689	0.007	CcSEcCtD
Methocarbamol—Pain—Chlorambucil—ovarian cancer	0.00682	0.00693	CcSEcCtD
Methocarbamol—Angioedema—Vinorelbine—ovarian cancer	0.0068	0.00691	CcSEcCtD
Methocarbamol—Vertigo—Vinorelbine—ovarian cancer	0.00669	0.00679	CcSEcCtD
Methocarbamol—Coordination abnormal—Epirubicin—ovarian cancer	0.00667	0.00677	CcSEcCtD
Methocarbamol—Leukopenia—Vinorelbine—ovarian cancer	0.00666	0.00677	CcSEcCtD
Methocarbamol—Feeling abnormal—Chlorambucil—ovarian cancer	0.00657	0.00668	CcSEcCtD
Methocarbamol—Hypotension—Melphalan—ovarian cancer	0.0065	0.0066	CcSEcCtD
Methocarbamol—Urticaria—Chlorambucil—ovarian cancer	0.00634	0.00644	CcSEcCtD
Methocarbamol—Body temperature increased—Chlorambucil—ovarian cancer	0.0063	0.0064	CcSEcCtD
Methocarbamol—Dyspepsia—Topotecan—ovarian cancer	0.00625	0.00635	CcSEcCtD
Methocarbamol—Conjunctivitis—Paclitaxel—ovarian cancer	0.00623	0.00632	CcSEcCtD
Methocarbamol—Coordination abnormal—Doxorubicin—ovarian cancer	0.00617	0.00627	CcSEcCtD
Methocarbamol—Dyspepsia—Melphalan—ovarian cancer	0.00612	0.00622	CcSEcCtD
Methocarbamol—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00607	0.00617	CcSEcCtD
Methocarbamol—Pain—Topotecan—ovarian cancer	0.00607	0.00617	CcSEcCtD
Methocarbamol—Pain—Melphalan—ovarian cancer	0.00594	0.00604	CcSEcCtD
Methocarbamol—Hypersensitivity—Chlorambucil—ovarian cancer	0.00588	0.00597	CcSEcCtD
Methocarbamol—Bradycardia—Paclitaxel—ovarian cancer	0.00585	0.00595	CcSEcCtD
Methocarbamol—Feeling abnormal—Topotecan—ovarian cancer	0.00585	0.00594	CcSEcCtD
Methocarbamol—Hypotension—Vinorelbine—ovarian cancer	0.00567	0.00577	CcSEcCtD
Methocarbamol—Pruritus—Chlorambucil—ovarian cancer	0.00564	0.00573	CcSEcCtD
Methocarbamol—Urticaria—Topotecan—ovarian cancer	0.00564	0.00573	CcSEcCtD
Methocarbamol—Body temperature increased—Topotecan—ovarian cancer	0.00561	0.0057	CcSEcCtD
Methocarbamol—Urticaria—Melphalan—ovarian cancer	0.00552	0.00561	CcSEcCtD
Methocarbamol—Thrombophlebitis—Epirubicin—ovarian cancer	0.00549	0.00558	CcSEcCtD
Methocarbamol—Flushing—Paclitaxel—ovarian cancer	0.00534	0.00542	CcSEcCtD
Methocarbamol—Jaundice—Docetaxel—ovarian cancer	0.00529	0.00538	CcSEcCtD
Methocarbamol—Conjunctivitis—Docetaxel—ovarian cancer	0.00528	0.00536	CcSEcCtD
Methocarbamol—Hypersensitivity—Topotecan—ovarian cancer	0.00523	0.00531	CcSEcCtD
Methocarbamol—Pain—Vinorelbine—ovarian cancer	0.00519	0.00528	CcSEcCtD
Methocarbamol—Hypersensitivity—Melphalan—ovarian cancer	0.00512	0.0052	CcSEcCtD
Methocarbamol—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00508	0.00516	CcSEcCtD
Methocarbamol—Vomiting—Chlorambucil—ovarian cancer	0.00507	0.00515	CcSEcCtD
Methocarbamol—Pruritus—Topotecan—ovarian cancer	0.00502	0.0051	CcSEcCtD
Methocarbamol—Feeling abnormal—Vinorelbine—ovarian cancer	0.005	0.00508	CcSEcCtD
Methocarbamol—Pruritus—Melphalan—ovarian cancer	0.00492	0.005	CcSEcCtD
Methocarbamol—Dysgeusia—Paclitaxel—ovarian cancer	0.0049	0.00498	CcSEcCtD
Methocarbamol—Urticaria—Vinorelbine—ovarian cancer	0.00482	0.0049	CcSEcCtD
Methocarbamol—Body temperature increased—Vinorelbine—ovarian cancer	0.0048	0.00488	CcSEcCtD
Methocarbamol—Diplopia—Epirubicin—ovarian cancer	0.00475	0.00483	CcSEcCtD
Methocarbamol—Nausea—Chlorambucil—ovarian cancer	0.00474	0.00481	CcSEcCtD
Methocarbamol—Vision blurred—Paclitaxel—ovarian cancer	0.00472	0.00479	CcSEcCtD
Methocarbamol—Dizziness—Topotecan—ovarian cancer	0.00469	0.00477	CcSEcCtD
Methocarbamol—Angioedema—Paclitaxel—ovarian cancer	0.00457	0.00465	CcSEcCtD
Methocarbamol—Flushing—Docetaxel—ovarian cancer	0.00452	0.00459	CcSEcCtD
Methocarbamol—Vomiting—Topotecan—ovarian cancer	0.00451	0.00459	CcSEcCtD
Methocarbamol—Vertigo—Paclitaxel—ovarian cancer	0.0045	0.00457	CcSEcCtD
Methocarbamol—Syncope—Paclitaxel—ovarian cancer	0.00449	0.00456	CcSEcCtD
Methocarbamol—Leukopenia—Paclitaxel—ovarian cancer	0.00448	0.00455	CcSEcCtD
Methocarbamol—Rash—Topotecan—ovarian cancer	0.00448	0.00455	CcSEcCtD
Methocarbamol—Hypersensitivity—Vinorelbine—ovarian cancer	0.00447	0.00455	CcSEcCtD
Methocarbamol—Dermatitis—Topotecan—ovarian cancer	0.00447	0.00454	CcSEcCtD
Methocarbamol—Headache—Topotecan—ovarian cancer	0.00445	0.00452	CcSEcCtD
Methocarbamol—Vomiting—Melphalan—ovarian cancer	0.00442	0.00449	CcSEcCtD
Methocarbamol—Loss of consciousness—Paclitaxel—ovarian cancer	0.0044	0.00447	CcSEcCtD
Methocarbamol—Diplopia—Doxorubicin—ovarian cancer	0.0044	0.00447	CcSEcCtD
Methocarbamol—Rash—Melphalan—ovarian cancer	0.00438	0.00445	CcSEcCtD
Methocarbamol—Dermatitis—Melphalan—ovarian cancer	0.00438	0.00445	CcSEcCtD
Methocarbamol—Convulsion—Paclitaxel—ovarian cancer	0.00434	0.00441	CcSEcCtD
Methocarbamol—Pruritus—Vinorelbine—ovarian cancer	0.0043	0.00436	CcSEcCtD
Methocarbamol—Nausea—Topotecan—ovarian cancer	0.00422	0.00428	CcSEcCtD
Methocarbamol—Dysgeusia—Docetaxel—ovarian cancer	0.00415	0.00422	CcSEcCtD
Methocarbamol—Nausea—Melphalan—ovarian cancer	0.00413	0.00419	CcSEcCtD
Methocarbamol—Confusional state—Paclitaxel—ovarian cancer	0.00412	0.00418	CcSEcCtD
Methocarbamol—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00408	0.00415	CcSEcCtD
Methocarbamol—Shock—Paclitaxel—ovarian cancer	0.00402	0.00408	CcSEcCtD
Methocarbamol—Dizziness—Vinorelbine—ovarian cancer	0.00402	0.00408	CcSEcCtD
Methocarbamol—Vomiting—Vinorelbine—ovarian cancer	0.00386	0.00392	CcSEcCtD
Methocarbamol—Rash—Vinorelbine—ovarian cancer	0.00383	0.00389	CcSEcCtD
Methocarbamol—Dermatitis—Vinorelbine—ovarian cancer	0.00383	0.00389	CcSEcCtD
Methocarbamol—Hypotension—Paclitaxel—ovarian cancer	0.00382	0.00388	CcSEcCtD
Methocarbamol—Headache—Vinorelbine—ovarian cancer	0.0038	0.00387	CcSEcCtD
Methocarbamol—Syncope—Docetaxel—ovarian cancer	0.0038	0.00386	CcSEcCtD
Methocarbamol—Leukopenia—Docetaxel—ovarian cancer	0.0038	0.00386	CcSEcCtD
Methocarbamol—Loss of consciousness—Docetaxel—ovarian cancer	0.00373	0.00379	CcSEcCtD
Methocarbamol—Insomnia—Paclitaxel—ovarian cancer	0.00369	0.00375	CcSEcCtD
Methocarbamol—Convulsion—Docetaxel—ovarian cancer	0.00368	0.00373	CcSEcCtD
Methocarbamol—Drowsiness—Epirubicin—ovarian cancer	0.00366	0.00372	CcSEcCtD
Methocarbamol—Somnolence—Paclitaxel—ovarian cancer	0.00363	0.00369	CcSEcCtD
Methocarbamol—Nausea—Vinorelbine—ovarian cancer	0.00361	0.00366	CcSEcCtD
Methocarbamol—Dyspepsia—Paclitaxel—ovarian cancer	0.0036	0.00365	CcSEcCtD
Methocarbamol—Jaundice—Epirubicin—ovarian cancer	0.00357	0.00363	CcSEcCtD
Methocarbamol—Conjunctivitis—Epirubicin—ovarian cancer	0.00356	0.00362	CcSEcCtD
Methocarbamol—Pain—Paclitaxel—ovarian cancer	0.00349	0.00355	CcSEcCtD
Methocarbamol—Confusional state—Docetaxel—ovarian cancer	0.00349	0.00355	CcSEcCtD
Methocarbamol—Anaphylactic shock—Docetaxel—ovarian cancer	0.00346	0.00352	CcSEcCtD
Methocarbamol—Shock—Docetaxel—ovarian cancer	0.00341	0.00346	CcSEcCtD
Methocarbamol—Drowsiness—Doxorubicin—ovarian cancer	0.00339	0.00344	CcSEcCtD
Methocarbamol—Feeling abnormal—Paclitaxel—ovarian cancer	0.00337	0.00342	CcSEcCtD
Methocarbamol—Bradycardia—Epirubicin—ovarian cancer	0.00335	0.0034	CcSEcCtD
Methocarbamol—Jaundice—Doxorubicin—ovarian cancer	0.0033	0.00335	CcSEcCtD
Methocarbamol—Conjunctivitis—Doxorubicin—ovarian cancer	0.00329	0.00335	CcSEcCtD
Methocarbamol—Urticaria—Paclitaxel—ovarian cancer	0.00325	0.0033	CcSEcCtD
Methocarbamol—Hypotension—Docetaxel—ovarian cancer	0.00324	0.00329	CcSEcCtD
Methocarbamol—Body temperature increased—Paclitaxel—ovarian cancer	0.00323	0.00328	CcSEcCtD
Methocarbamol—Insomnia—Docetaxel—ovarian cancer	0.00313	0.00318	CcSEcCtD
Methocarbamol—Bradycardia—Doxorubicin—ovarian cancer	0.0031	0.00315	CcSEcCtD
Methocarbamol—Somnolence—Docetaxel—ovarian cancer	0.00308	0.00313	CcSEcCtD
Methocarbamol—Flushing—Epirubicin—ovarian cancer	0.00305	0.0031	CcSEcCtD
Methocarbamol—Dyspepsia—Docetaxel—ovarian cancer	0.00305	0.0031	CcSEcCtD
Methocarbamol—Hypersensitivity—Paclitaxel—ovarian cancer	0.00301	0.00306	CcSEcCtD
Methocarbamol—Pain—Docetaxel—ovarian cancer	0.00296	0.00301	CcSEcCtD
Methocarbamol—Pruritus—Paclitaxel—ovarian cancer	0.00289	0.00294	CcSEcCtD
Methocarbamol—Feeling abnormal—Docetaxel—ovarian cancer	0.00285	0.0029	CcSEcCtD
Methocarbamol—Flushing—Doxorubicin—ovarian cancer	0.00282	0.00287	CcSEcCtD
Methocarbamol—Dysgeusia—Epirubicin—ovarian cancer	0.0028	0.00285	CcSEcCtD
Methocarbamol—Carvedilol—ABCB1—ovarian cancer	0.00276	0.177	CrCbGaD
Methocarbamol—Body temperature increased—Docetaxel—ovarian cancer	0.00274	0.00278	CcSEcCtD
Methocarbamol—Dizziness—Paclitaxel—ovarian cancer	0.0027	0.00274	CcSEcCtD
Methocarbamol—Vision blurred—Epirubicin—ovarian cancer	0.0027	0.00274	CcSEcCtD
Methocarbamol—Vomiting—Paclitaxel—ovarian cancer	0.0026	0.00264	CcSEcCtD
Methocarbamol—Dysgeusia—Doxorubicin—ovarian cancer	0.00259	0.00263	CcSEcCtD
Methocarbamol—Rash—Paclitaxel—ovarian cancer	0.00258	0.00262	CcSEcCtD
Methocarbamol—Dermatitis—Paclitaxel—ovarian cancer	0.00257	0.00261	CcSEcCtD
Methocarbamol—Vertigo—Epirubicin—ovarian cancer	0.00257	0.00261	CcSEcCtD
Methocarbamol—Syncope—Epirubicin—ovarian cancer	0.00257	0.00261	CcSEcCtD
Methocarbamol—Leukopenia—Epirubicin—ovarian cancer	0.00256	0.0026	CcSEcCtD
Methocarbamol—Headache—Paclitaxel—ovarian cancer	0.00256	0.0026	CcSEcCtD
Methocarbamol—Hypersensitivity—Docetaxel—ovarian cancer	0.00255	0.00259	CcSEcCtD
Methocarbamol—Loss of consciousness—Epirubicin—ovarian cancer	0.00252	0.00255	CcSEcCtD
Methocarbamol—Vision blurred—Doxorubicin—ovarian cancer	0.0025	0.00253	CcSEcCtD
Methocarbamol—Convulsion—Epirubicin—ovarian cancer	0.00248	0.00252	CcSEcCtD
Methocarbamol—Pruritus—Docetaxel—ovarian cancer	0.00245	0.00249	CcSEcCtD
Methocarbamol—Nausea—Paclitaxel—ovarian cancer	0.00243	0.00246	CcSEcCtD
Methocarbamol—Vertigo—Doxorubicin—ovarian cancer	0.00238	0.00242	CcSEcCtD
Methocarbamol—Syncope—Doxorubicin—ovarian cancer	0.00237	0.00241	CcSEcCtD
Methocarbamol—Leukopenia—Doxorubicin—ovarian cancer	0.00237	0.00241	CcSEcCtD
Methocarbamol—Confusional state—Epirubicin—ovarian cancer	0.00235	0.00239	CcSEcCtD
Methocarbamol—Anaphylactic shock—Epirubicin—ovarian cancer	0.00234	0.00237	CcSEcCtD
Methocarbamol—Loss of consciousness—Doxorubicin—ovarian cancer	0.00233	0.00236	CcSEcCtD
Methocarbamol—Shock—Epirubicin—ovarian cancer	0.0023	0.00233	CcSEcCtD
Methocarbamol—Convulsion—Doxorubicin—ovarian cancer	0.00229	0.00233	CcSEcCtD
Methocarbamol—Dizziness—Docetaxel—ovarian cancer	0.00229	0.00233	CcSEcCtD
Methocarbamol—Vomiting—Docetaxel—ovarian cancer	0.0022	0.00224	CcSEcCtD
Methocarbamol—Rash—Docetaxel—ovarian cancer	0.00218	0.00222	CcSEcCtD
Methocarbamol—Hypotension—Epirubicin—ovarian cancer	0.00218	0.00222	CcSEcCtD
Methocarbamol—Dermatitis—Docetaxel—ovarian cancer	0.00218	0.00222	CcSEcCtD
Methocarbamol—Confusional state—Doxorubicin—ovarian cancer	0.00218	0.00221	CcSEcCtD
Methocarbamol—Headache—Docetaxel—ovarian cancer	0.00217	0.0022	CcSEcCtD
Methocarbamol—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00216	0.0022	CcSEcCtD
Methocarbamol—Shock—Doxorubicin—ovarian cancer	0.00213	0.00216	CcSEcCtD
Methocarbamol—Insomnia—Epirubicin—ovarian cancer	0.00211	0.00215	CcSEcCtD
Methocarbamol—Propranolol—ABCB1—ovarian cancer	0.0021	0.134	CrCbGaD
Methocarbamol—Somnolence—Epirubicin—ovarian cancer	0.00208	0.00211	CcSEcCtD
Methocarbamol—Nausea—Docetaxel—ovarian cancer	0.00206	0.00209	CcSEcCtD
Methocarbamol—Dyspepsia—Epirubicin—ovarian cancer	0.00206	0.00209	CcSEcCtD
Methocarbamol—Hypotension—Doxorubicin—ovarian cancer	0.00202	0.00205	CcSEcCtD
Methocarbamol—Pain—Epirubicin—ovarian cancer	0.002	0.00203	CcSEcCtD
Methocarbamol—Insomnia—Doxorubicin—ovarian cancer	0.00195	0.00199	CcSEcCtD
Methocarbamol—Feeling abnormal—Epirubicin—ovarian cancer	0.00192	0.00196	CcSEcCtD
Methocarbamol—Somnolence—Doxorubicin—ovarian cancer	0.00192	0.00195	CcSEcCtD
Methocarbamol—Dyspepsia—Doxorubicin—ovarian cancer	0.0019	0.00193	CcSEcCtD
Methocarbamol—Urticaria—Epirubicin—ovarian cancer	0.00186	0.00188	CcSEcCtD
Methocarbamol—Pain—Doxorubicin—ovarian cancer	0.00185	0.00188	CcSEcCtD
Methocarbamol—Body temperature increased—Epirubicin—ovarian cancer	0.00185	0.00188	CcSEcCtD
Methocarbamol—Feeling abnormal—Doxorubicin—ovarian cancer	0.00178	0.00181	CcSEcCtD
Methocarbamol—Hypersensitivity—Epirubicin—ovarian cancer	0.00172	0.00175	CcSEcCtD
Methocarbamol—Urticaria—Doxorubicin—ovarian cancer	0.00172	0.00174	CcSEcCtD
Methocarbamol—Body temperature increased—Doxorubicin—ovarian cancer	0.00171	0.00174	CcSEcCtD
Methocarbamol—Pruritus—Epirubicin—ovarian cancer	0.00165	0.00168	CcSEcCtD
Methocarbamol—Hypersensitivity—Doxorubicin—ovarian cancer	0.00159	0.00162	CcSEcCtD
Methocarbamol—Dizziness—Epirubicin—ovarian cancer	0.00154	0.00157	CcSEcCtD
Methocarbamol—Pruritus—Doxorubicin—ovarian cancer	0.00153	0.00155	CcSEcCtD
Methocarbamol—Vomiting—Epirubicin—ovarian cancer	0.00148	0.00151	CcSEcCtD
Methocarbamol—Rash—Epirubicin—ovarian cancer	0.00147	0.0015	CcSEcCtD
Methocarbamol—Dermatitis—Epirubicin—ovarian cancer	0.00147	0.00149	CcSEcCtD
Methocarbamol—Headache—Epirubicin—ovarian cancer	0.00146	0.00149	CcSEcCtD
Methocarbamol—Dizziness—Doxorubicin—ovarian cancer	0.00143	0.00145	CcSEcCtD
Methocarbamol—Nausea—Epirubicin—ovarian cancer	0.00139	0.00141	CcSEcCtD
Methocarbamol—Vomiting—Doxorubicin—ovarian cancer	0.00137	0.0014	CcSEcCtD
Methocarbamol—Rash—Doxorubicin—ovarian cancer	0.00136	0.00138	CcSEcCtD
Methocarbamol—Dermatitis—Doxorubicin—ovarian cancer	0.00136	0.00138	CcSEcCtD
Methocarbamol—Headache—Doxorubicin—ovarian cancer	0.00135	0.00138	CcSEcCtD
Methocarbamol—Nausea—Doxorubicin—ovarian cancer	0.00128	0.0013	CcSEcCtD
